Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
2007
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
2013
The secretory function of adipocytes in the physiology of white adipose tissue
2008
Adipose tissue, adipokines, and inflammation
2005 Standout
Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis
2008
Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
2011
Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action
2009 StandoutNobel
The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals
2007
Correlation of circulating full‐length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross‐sectional study
2008
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
2005 Standout
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
2007 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
The Adipose Tissue as an Endocrine Organ – A Nephrologists’ Perspective
2006
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Plasma Visfatin Concentration as a Surrogate Marker for Visceral Fat Accumulation in Obese Children
2008
Adipokines and Insulin Resistance
2008
Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women
2007
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians
2007
Serum concentration of visfatin in obese women
2007
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
2007
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus
2010
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
TLR4 links innate immunity and fatty acid–induced insulin resistance
2006 Standout
Adipokines in inflammation and metabolic disease
2011 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Elevated Visfatin/Pre-B-cell Colony-enhancing Factor Plasma Concentration in Ischemic Stroke
2009
Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action
2005
Enhanced Leptin-Stimulated Pi3k Activation in the CNS Promotes White Adipose Tissue Transdifferentiation
2007 StandoutNobel
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Adiponectin Levels and Risk of Type 2 Diabetes
2009 Standout
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
2013
NF-κB, Inflammation, and Metabolic Disease
2011 Standout
The release of the adipocytokine visfatin is regulated by glucose and insulin
2006
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2019
PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells
2008 StandoutNobel
The current biology of resistin
2004
Plasma Visfatin Concentrations in Severely Obese Subjects Are Increased After Intestinal Bypass
2007
The role of adipokines in liver fibrosis
2008
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
What We Talk About When We Talk About Fat
2014 Standout
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
2013 Standout
Reduced Plasma Visfatin/Pre-B Cell Colony-Enhancing Factor in Obesity Is Not Related to Insulin Resistance in Humans
2006
Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study
2004
Macrophage M1/M2 polarization
2020 Standout
Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients
2010
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Resistin: molecular history and prognosis
2003
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
An Inflammatory Cascade Leading to Hyperresistinemia in Humans
2004
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
2007 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
2009 Standout
NAD + /NADH and NADP + /NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences
2007 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
2014
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Regulation of Fasted Blood Glucose by Resistin
2004 Science
Adipokines and the cardiovascular system: mechanisms mediating health and disease
2012
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine
2008
Insulin Hypersensitivity and Resistance to Streptozotocin-Induced Diabetes in Mice Lacking PTEN in Adipose Tissue
2005
Resistin: an adipocyte‐derived hormone. Has it a role in diabetes and obesity?
2004
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Lipotoxicity versus adipotoxicity—The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes
2006
Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease
2005
Essential Role of Pten in Body Size Determination and Pancreatic β-Cell Homeostasis In Vivo
2006 StandoutNobel
The Metabolic Syndrome
2008 Standout
Clinical Correlates of Circulating Visfatin Levels in a Community-Based Sample
2007
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Adipocytokines and the Metabolic Complications of Obesity
2008
Deletion of Pten in Pancreatic β-Cells Protects Against Deficient β-Cell Mass and Function in Mouse Models of Type 2 Diabetes
2010 StandoutNobel
The Adipokine Visfatin is Markedly Elevated in Obese Children
2006
Works of Dao‐Ming Chang being referenced
Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus
2006
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review
2011
Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus
2006
Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
2018
Peripheral Total and Differential Leukocyte Count in Diabetic Nephropathy
2005
Association of Resistin Gene 3′-Untranslated Region +62G→A Polymorphism with Type 2 Diabetes and Hypertension in a Chinese Population
2003